|
Published by: Draco Healthcare Consulting LLC
Published: Oct. 1, 2009 - 55 Pages
Table of Contents
- Methodology
- Overview
- Section 1: China Benign Prostate Hyperplasia (BPH) Drug Market
- 1.1 Competition landscape of the Chinese BPH hospital drug market
- 1.2 Manufacturers and their market shares in the Chinese BPH drug market
- Section 2: China Asthma Drug Market
- 2.1 Competition landscape of the Chinese asthma drug market
- 2.2 Manufacturers and their market shares in the Chinese asthma drug market
- Section 3: China Depression Drug Market
- 3.1 Competition landscape of the Chinese depression drug market
- 3.2 Manufacturers and their market shares in the Chinese depression drug market
- Section 4: China Dementia Drug Market
- 4.1 Competition landscape of the Chinese dementia drug market
- 4.2 Manufacturers and their market shares of the Chinese dementia drug market
- Section 5: China Cancer Drug Market
- 5.1 Competition landscape of the Chinese cancer drug market
- 5.2 Manufacturers and their market shares in the Chinese cancer drug market
- Section 6: The China Allergy Drug Market
- 6.1 Competition landscape of the Chinese allergy drug market
- 6.2 Manufacturers and their market shares in the Chinese allergy drug market
- Section 7: China Hypertension Drug Market
- 7.1 Competition landscape of the Chinese hypertension drug market
- 7.2 Manufacturers and their market shares in the Chinese hypertension drug market
- Section 8: Dermatosis Drug Market
- 8.1 Competition landscape of the Chinese dermatosis drug market
- 8.2 Manufacturers and their market shares in the Chinese dermatosis drug market
- Section 9: China Ophthalmological Drug Market
- 9.1 Competition landscape in the Chinese ophthalmological drug market
- 9.2 Manufacturers and their market shares in the Chinese ophthalmological drug market
- Section 10: China Rheumatoid Arthritis (RA) Drug Market
- 10.1 Competition landscape of the Chinese RA drug market
- 10.2 Manufacturers and their market shares in the Chinese RA drug market
- Section 11: China Diabetes Drug Market
- 11.1 Competition landscape of the Chinese diabetes drug market
- 11.2 Manufacturers and their market shares in the Chinese diabetes drug market in 2008
- Section 12: Liver Disease Drug Market
- 12.1. Competition landscape of the Chinese liver disease drug market
- 12.2 Manufacturers, their market shares and sales in the Chinese liver disease drug market in 2008
- Section 13: China Blood Product Market
- 13.1 Competition landscape of the Chinese blood product market
- 13. 2 Manufacturers and their market shares in the Chinese blood product market
- Section 14: China Hypolipidemics Drug Market
- 14.1 Competition landscape of the Chinese hypolipidemics drug market
- 14.2 Manufacturers and their market shares in the Chinese hypolipidemics drug market 55 Table1 Sample hospital coverage for the drug prescription data in China
- List of Tables
- Table 2 Key disease areas and their market sizes in China in 2008
- Table 3 Ranking, market shares, sales and AGR of top 15 BPH drugs in the Chinese market in 2008
- Table 4 Ranking, market shares, sales and AGR of the top 20 manufacturers of BPH drugs in the Chinese market in 2008
- Table 5 Ranking, market shares, sales and AGR of top 20 asthma drugs in the Chinese market in 2008
- Table 6 Ranking, market shares, sales and AGR of the top 20 manufacturers of asthma drugs in the Chinese market in 2008
- Table 7 Ranking, market shares, sales and AGR of top 20 depression drugs in the Chinese market in 2008
- Table 8 Ranking, market shares, sales and AGR of the top 20 manufacturers of depression drugs in the Chinese market in 2008
- Table 9 Ranking, market shares, sales and AGR of top 20 dementia drugs in the Chinese market in 2008
- Table 10 Ranking, market shares, sales and AGR of the top 20 manufacturers of dementia drugs in the Chinese market in 2008
- Table 11 Ranking, market shares, sales and AGR of top 20 cancer drugs in the Chinese market in 2008
- Table 12 Ranking, market shares, sales and AGR of the top 20 manufacturers of cancer drugs in the Chinese market in 2008
- Table 13 Ranking, market shares, sales and AGR of top 15 allergy drugs in the Chinese market in 2008
- Table 14 Ranking, market shares, sales and AGR of the top 20 manufacturers of allergy drugs in the Chinese market in 2008
- Table 15 Ranking, market shares, sales and AGR of top 20 hypertension drugs in the Chinese market in 2008
- Table 16 Ranking, market shares, sales and AGR of the top 20 manufacturers of hypertension drugs in the Chinese market in 2008
- Table 17 Ranking, market shares, sales and AGR of top 20 dermatosis drugs in the Chinese market in 2008
- Table 18 Ranking, market shares, sales and AGR of the top 20 manufacturers of dermatosis drugs in the Chinese market in 2008
- Table 19 Ranking, market shares, sales and AGR of top 20 ophthalmological drugs in the Chinese market in 2008
- Table 20 Ranking, market shares, sales and AGR of the top 20 manufacturers of ophthalmological drugs in the Chinese market in 2008
- Table 21 Ranking, market shares, sales and AGR of top 20 RA drugs in the Chinese market in 2008
- Table 22 Ranking, market shares, sales and AGR of the top 20 manufacturers of RA drugs in the Chinese market in 2008
- Table 23 Ranking, market shares, sales and AGR of top 10 diabetes drugs in the Chinese market in 2008
- Table 24 Ranking, market shares, sales and AGR of the top 20 manufacturers of diabetes drugs in the Chinese market in 2008
- Table 25 Ranking, market shares, sales and AGR of top 20 liver disease drugs in the Chinese market in 2008
- Table 26 Ranking, market shares, sales and AGR of the top 20 manufacturers of liver disease drugs in the Chinese market in 2008
- Table 27 Ranking, market shares, sales and AGR of top 20 blood products in the Chinese market in 2008
- Table 28 Ranking, market shares, sales and AGR of the top 20 manufacturers of blood products in the Chinese market in 2008
- Table 29 Ranking, market shares, sales and AGR of top 20 hypolipidemics drugs in the Chinese market in 2008
- Table 30 Ranking, market shares, sales and AGR of the top 20 manufacturers of hypolipidemics in the Chinese market in 2008
AbstractThe total Chinese pharmaceutical market had reached RMB 828.36 billion (US$ 120.84 billion, at an exchange rate of US $1 = RMB 6.83) with an annual growth rate (AGR) of 26.50% in 2008. The growth rate, as well as the absolute size of the rapidly-expanding Chinese pharmaceutical market, is no doubt astonishing. The categorization of the Chinese pharmaceutical market as one of the “emerging pharmaceutical market” may need to be reconsidered.
Even though the current Chinese pharmaceutical market is still mainly a generic market, many of the innovative drugs have been rapidly up-taken by large Chinese hospitals in major cities. Some of the highly-priced oncology drugs, for example, erlotinib and trastuzumab, have made into the list of top 20 cancer drugs (by sales) in the last few years.
Many pharmaceutical companies have realized that just locking their eyes at the “mature” pharmaceutical markets (US, Europe and Japan) is no longer enough to sustain growth, especially for the future growth.
This Second Edition of the China Pharma Executive Summary provides hospital drug utilization data for 14 key therapeutic areas, including asthma, cancer, liver diseases, diabetes, hypertension, depression, allergy, dementia, benign prostate hyperplasia (BPH), ophthalmology, hyperlipoidemia, rheumatoid arthritis, dermatosis, and blood products, etc.
Key contents include:
- 2008 annual drug sales in the Chinese hospital market for each therapeutic area*.
- Sales and market shares of top 20 manufacturers in each therapeutic area.
- Sales and market shares of top drugs in each therapeutic area.
Annual drug sales in each of the eight therapeutic areas (cancer, blood diseases, liver diseases, dermatosis, hypertension, diabetes, dementia, and hyperlipidemics) had passed US $1 billion in 2008. Sales of cancer drugs in the Chinese hospital market reached US $4.612 billion, followed immediately by blood products which had US $3.966 billion in 2008. Except skin disease, eye disease, allergy and BPH, drug sales in all other therapeutic areas had achieved double digit growth rates in 2008. *: Drug prices are based on the hospital drug purchase prices in 2008 for all drug utilization data in this report.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
